Excalipoint Therapeutics develops targeted therapies that focus on modulating disease pathways at specific biological points. The company applies research in molecular biology and drug discovery to design treatments for conditions with limited therapeutic options. Its work includes identifying precise intervention mechanisms and translating them into clinical candidates through preclinical and cli...